Economy
-
-
Okta in focus as Needham ups price target ahead of conference
-
Celanese raises prices across global acetyl chain
-
J.P. Morgan and Qatar Investment Authority ink $20B partnership
-
Alkermes rises on phase 1 results for ADHD drug ALKS 7290
-
Founder Group receives Nasdaq notification
-
Stifel reiterates Oracle stock Buy rating amid data center progress
-
Stifel reiterates Buy on DigitalOcean stock after database launch
-
Stifel reiterates Okta stock Buy rating after board changes
-
Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up